New York State Common Retirement Fund Has $7.22 Million Stock Holdings in AdaptHealth Corp. (NASDAQ:AHCO)

New York State Common Retirement Fund boosted its position in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 25.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 758,562 shares of the company’s stock after purchasing an additional 151,638 shares during the period. New York State Common Retirement Fund owned 0.56% of AdaptHealth worth $7,222,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of AHCO. Intech Investment Management LLC raised its holdings in AdaptHealth by 223.2% during the third quarter. Intech Investment Management LLC now owns 59,650 shares of the company’s stock valued at $670,000 after buying an additional 41,196 shares in the last quarter. Victory Capital Management Inc. increased its holdings in shares of AdaptHealth by 727.4% during the 3rd quarter. Victory Capital Management Inc. now owns 141,507 shares of the company’s stock valued at $1,589,000 after acquiring an additional 124,404 shares during the last quarter. Royce & Associates LP raised its stake in shares of AdaptHealth by 13.5% in the 3rd quarter. Royce & Associates LP now owns 777,405 shares of the company’s stock valued at $8,730,000 after acquiring an additional 92,740 shares in the last quarter. Barclays PLC raised its stake in shares of AdaptHealth by 361.3% in the 3rd quarter. Barclays PLC now owns 181,240 shares of the company’s stock valued at $2,034,000 after acquiring an additional 141,949 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in AdaptHealth by 39.7% in the 3rd quarter. Principal Financial Group Inc. now owns 543,744 shares of the company’s stock worth $6,106,000 after purchasing an additional 154,434 shares during the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Stock Performance

Shares of AdaptHealth stock opened at $11.10 on Thursday. The firm has a fifty day moving average of $9.87 and a two-hundred day moving average of $10.21. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The stock has a market capitalization of $1.49 billion, a price-to-earnings ratio of -6.73, a PEG ratio of 1.08 and a beta of 1.12. AdaptHealth Corp. has a 52 week low of $8.35 and a 52 week high of $11.90.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on AHCO shares. Royal Bank of Canada raised their target price on shares of AdaptHealth from $11.00 to $14.00 and gave the company an “outperform” rating in a research note on Wednesday. UBS Group lowered their price target on AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Canaccord Genuity Group boosted their price objective on AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday. Robert W. Baird decreased their target price on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research note on Wednesday, November 6th. Finally, Truist Financial lifted their price target on AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $13.40.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.